Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization
Lacosamide
SP755
NCT00220415
Epilepsy
Phase 3
 
Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only
July 2014

Powered by ideaPoint, Inc.